Critical Care Medicine · 2013 · 54 citations · 34 references
AgricultureImmunologyNutritional SciencesClinical NutritionHuman NutritionNutritional PhysiologyCritical Care NutritionEnteral NutritionImmunonutrition In Clinical CareLipid NutritionNutrition SupportNutritional SupportAcute Inflammatory ResponseContinuous Enteral NutritionEnteral ImmunonutritionImmunomodulatory EffectsInflammatory Organ DamageLipopolysaccharide-induced DamageNasojejunal Tube FeedingNutrition In Critical Illness
OBJECTIVE: An overzealous inflammatory response is an important cause of morbidity and mortality in surgical, trauma, and critically ill patients. Enteral administration of lipid-rich nutrition was previously shown to attenuate inflammation and reduce organ damage via a cholecystokinin-1 receptor-mediated vagovagal reflex in animal studies. The current preclinical study investigates the immunomodulatory potential of a custom-made enteral nutrition during systemic inflammation in man. DESIGN: Double-blind, randomized controlled trial. SETTING: Intensive care research unit. SUBJECTS: Male volunteers. INTERVENTIONS: After an overnight fast, 18 healthy male subjects received an IV bolus of Escherichia coli lipopolysaccharide (2 ng/kg). Subjects in the fasted group (n = 6) were deprived of food throughout the study, while subjects in the intervention groups were fed either custom-made lipid- and protein-rich nutrition (n = 6) or isocaloric control nutrition (n = 6) via nasojejunal tube, starting 1 hour prior to lipopolysaccharide administration until 6 hours afterward. MEASUREMENTS AND MAIN RESULTS: Bolus lipopolysaccharide administration resulted in a marked inflammatory response. Continuous postpyloric administration of nutrition significantly increased plasma cholecystokinin levels throughout the lipopolysaccharide-induced inflammatory response. Lipid- and protein-rich nutrition attenuated circulating levels of the proinflammatory cytokines tumor necrosis factor-α and interleukin-6 and the interleukin-1 receptor antagonist compared with control nutrition (all p < 0.05) and fasted subjects (all p < 0.05). In additional, lipid- and protein-rich nutrition augmented the anti-inflammatory response, reflected by increased plasma levels of interleukin-10 compared with fasted subjects (p < 0.0001). CONCLUSIONS: The current preclinical study expands the immunomodulating effects of enteral nutrition as previously observed in rodents to man. Continuous administration of enteral nutrition resulted in a rapid anti-inflammatory effect. Furthermore, enrichment of the nutritional composition with lipid and protein was shown to enhance the anti-inflammatory potential. Therefore, continuous enteral administration of lipid- and protein-rich nutrition is a promising intervention to modulate the immune response in the early course of systemic inflammation in man.
34
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Hong Wang, Man Yu, Mahendar Ochani et al. · Nature · 2002 · 3.2K citations
ESPEN Guidelines on Parenteral Nutrition: Intensive care
Pierre Singer, Mette M. Berger, Greet Van den Berghe et al. · Clinical Nutrition · 2009 · 1.9K citations · Full text
ESPEN Guidelines on Enteral Nutrition: Intensive care
K. Georg Kreymann, Marc Moritz Berger, Nicolaas E.P. Deutz et al. · Clinical Nutrition · 2006 · 1.4K citations · Full text
Stephan Harbarth, K Holecková, Céline Froidevaux et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 908 citations
Interleukin 10 protects mice from lethal endotoxemia.
M Howard, Tony Muchamuel, Sílvia Passos Andrade et al. · The Journal of Experimental Medicine · 1993 · 793 citations · Full text